Diplomat welcomes patients with common variable immunodeficiency (CVID) and supports them with treatment and answers. Throughout therapy, we provide advice on funding and 24/7 clinical support, so patients are always informed. We’re here to make sure patients’ access to their prescribed intravenous immune globulin or other microbacterial treatments is uninterrupted. That’s why we reach out before each refill to coordinate delivery and address side effects and concerns. Along the way, we communicate between all members of the health care team, making sure everyone is informed and that the patient is always put first.
Common Variable Immunodeficiency
One of the first steps after a common variable immunodeficiency (CVID) diagnosis is understanding the condition. The information on this site and linked sites is not meant to replace your physician’s advice, medical care or a diagnosis. If you have questions about your disease, please ask your prescriber.
Patients with common variable immunodeficiency are more prone to sickness than the rest of the population. This is due to a low level of immune globulin (antibodies), possibly due to a genetic defect.
CVID, also known as hypogammaglobulinemia, typically is diagnosed within a child’s first year. As the mother’s protective antibodies wear off, the infant becomes susceptible to bacterial infection. Common infections include respiratory illness, gastrointestinal disorders and autoimmune diseases.
Regular treatment can help CVID patients live normal, healthy lifestyles.
The information contained herein may not be construed as medical advice. It is for educational purposes only. Diplomat Pharmacy Inc. takes no responsibility for the accuracy or validity of the information contained herein, nor the claims or statements of any manufacturer.